Skip to content

Tate & Lyle

Country not established

Devices
1

What Tate & Lyle makes

Tate & Lyle manufactures MIRA-FLO STARCH, a medical-grade starch used as a surgical hemostatic agent to control bleeding during procedures. This product is designed to be applied directly to bleeding sites to promote clotting and reduce transfusion requirements in surgical settings.

The MIRA-FLO STARCH device is classified under FDA’s Premarket Approval (PMA) category, indicating it undergoes rigorous review for high-risk surgical applications. The product is listed with the U.S. Food and Drug Administration, adhering to regulatory standards for medical devices in the United States.

AI-generated from registry data, 20 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Mira-Flo Starch Ref P900016

    Withdrawn Regimes: PMA, withdrawn Registry: PMA Class:—

Frequently asked questions

How many devices does Tate & Lyle have in the registry?

The registry currently lists 1 device for Tate & Lyle. Devices recorded under merged duplicate company entries are counted once.

Which registries list Tate & Lyle's devices?

Among its 1 most recently registered device, Tate & Lyle has devices listed in FDA PMA (1 device).

What are the newest devices from Tate & Lyle in the registry?

The most recently registered devices listed for Tate & Lyle include MIRA-FLO STARCH.

Generated automatically from registry data and not verified by a human reviewer.